Table of Contents
1 Industry Outlook 8
1.1 Industry Overview 8
1.2 Total Addressable Market 8
1.3 Industry Trends 9
2 Report Outline 10
2.1 Report Scope 10
2.2 Report Summary 10
2.3 Research Methodology 11
2.4 Report Assumptions 11
3 Market Snapshot 12
3.1 Market Definition - Infoholic Research 13
3.2 Segmented Addressable Market (SAM) 13
3.2.1 Evolution of Stem Cell Banking 13
3.2.2 Advantages of Stem Cell 15
3.3 Steps involved in the Stem Cell Banking 16
3.4 Trends of Stem Cell Banking Market 19
3.5 Related Addressable Markets (RAM) 21
3.5.1 Genome Engineering 21
3.5.2 Single Cell Analysis 21
4 Market Outlook 22
4.1 Overview 22
4.2 Market Segmentation 23
4.3 Porter 5(Five) Forces 23
4.4 PEST Analysis 24
5 Market Characteristics 25
5.1 Market Dynamics 26
5.1.1 Drivers 26
5.1.1.1 Easy Stem Cell Extraction Method from The Sample 26
5.1.1.2 Increasing global Birth-rate 26
5.1.1.3 Potentials of stem cell in treatment of various diseases 26
5.1.2 Opportunities 27
5.1.2.1 Increasing investment in Stem Cell Banking 27
5.1.2.2 Merger and Acquisition 27
5.1.3 Restraints 28
5.1.3.1 High operating cost 28
5.1.3.2 Lack of acceptance 28
5.1.3.3 Government Regulation 28
5.1.4 DRO - Impact Analysis 29
5.1.5 Key Stakeholders 29
6 Source Types: Market Size and Analysis 31
6.1 Overview 31
6.1.1 Umbilical Cord Blood and Tissue Banking 31
6.1.2 Adult Stem Cell Banking 33
7 Stem Cell Bank Types: Market Size and Analysis 35
7.1 Overview 35
7.1.1 Private Stem Cell Banks 35
7.1.2 Public Stem Cell Banks 36
8 Regions: Market Size and Analysis 37
8.1 Overview 37
8.2 North America 38
8.2.1 Overview 38
8.2.2 US 38
8.2.3 Canada 39
8.3 Europe 39
8.3.1 Overview 39
8.3.1.1 UK 40
8.3.1.2 Germany 40
8.3.1.3 France 41
8.3.1.4 Italy 41
8.4 APAC 41
8.4.1 Overview 41
8.4.1.1 India 42
8.4.1.2 Taiwan 43
8.4.1.3 China 43
8.5 Rest of the World 44
8.5.1 Overview 44
8.5.1.1 Brazil 45
8.5.1.2 South Africa 45
8.5.1.3 Ecuador 46
9 Competitive Landscape 47
10 Vendor Profiles 50
10.1 Esperite N.V. 50
10.1.1 Overview 50
10.1.2 Business Unit 51
10.1.3 Geographic Presence 52
10.1.4 Business Focus 53
10.1.5 SWOT Analysis 53
10.1.6 Business Strategy 54
10.2 Caladrius Biosciences' Inc. 55
10.2.1 Overview 55
10.2.2 Business Unit 58
10.2.3 Business Focus 59
10.2.4 SWOT Analysis 59
10.2.5 Business Strategy 59
10.3 Cryo-Cell International 60
10.3.1 Overview 60
10.3.2 Highlights 61
10.4 China Cord Blood Corporation. 62
10.4.1 Overview 62
10.4.2 SWOT Analysis 63
10.4.3 Business Strategy 63
10.5 StemCyte India Therapeutics Pvt. Ltd.' 63
10.5.1 Overview 63
10.5.2 Highlights 64
10.6 CBR Systems Inc. 64
10.6.1 Overview 64
10.6.2 Highlights 64
10.7 Smart Cell UK 65
10.7.1 Overview 65
10.7.2 Highlights 65
10.8 LifeCell. 65
10.8.1 Overview 65
10.8.2 Highlights 66
10.9 CordVida 67
10.9.1 Overview 67
10.9.2 Highlights 67
10.10 ViaCord 67
10.10.1 Overview 67
10.10.2 Highlights 68
10.11 Cryo-Cell International 68
10.11.1 Overview 68
10.12 Cryoviva Biotech Pvt Ltd 68
10.12.1 Overview 68
10.12.2 Highlights 69
Annexure 69
Abbreviations 69